Last reviewed · How we verify
SHAPE Gel
At a glance
| Generic name | SHAPE Gel |
|---|---|
| Also known as | SHP-141 |
| Sponsor | TetraLogic Pharmaceuticals |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Post-market-clinical Follow-up Investigation of Safety and Performance by Decoria® Voluma (NA)
- Effect of Helfer Skin Tap and Cold Application on Pain and Hemodynamics During Vaccination (NA)
- Efficacy and Safety of Intravaginal EMS Treatments in Women With Exclusive or Predominant Stress Urinary Incontinence (NA)
- The Study is an Oberservational Post-market Follow-up Program to Evaluate Long Term(5 Years) Safety of Mentor Breast Implants in Chinese Population.
- Memory Gel and Shape Combined Cohort (NA)
- The Efficacy of Tocotrienol Rich Fraction for Liver Protection in Adult Patients With Alcoholic Fatty Liver Disease (AFLD) (PHASE2)
- Wearable Ultrasound Patch for Breast Imaging (NA)
- Performance of Reinforced 3D-Printed Versus Direct Bulk-Filled Resin Composites for Restoring Extensive Class II Cavities in Vital Molars (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- SHAPE Gel CI brief — competitive landscape report
- SHAPE Gel updates RSS · CI watch RSS
- TetraLogic Pharmaceuticals portfolio CI